Correlation Between Biofil Chemicals and Omeros

Can any of the company-specific risk be diversified away by investing in both Biofil Chemicals and Omeros at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofil Chemicals and Omeros into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biofil Chemicals Pharmaceuticals and Omeros, you can compare the effects of market volatilities on Biofil Chemicals and Omeros and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofil Chemicals with a short position of Omeros. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofil Chemicals and Omeros.

Diversification Opportunities for Biofil Chemicals and Omeros

-0.39

Correlation Coefficient

Biofil Chemicals  Omeros

Very good diversification

The 3 months correlation between Biofil and Omeros is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Biofil Chemicals Pharmaceutica and Omeros in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Omeros and Biofil Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofil Chemicals Pharmaceuticals are associated (or correlated) with Omeros. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Omeros has no effect on the direction of Biofil Chemicals i.e., Biofil Chemicals and Omeros go up and down completely randomly.

Pair Corralation between Biofil Chemicals and Omeros

Assuming the 90 days trading horizon Biofil Chemicals Pharmaceuticals is expected to under-perform the Omeros. But the stock apears to be less risky and, when comparing its historical volatility, Biofil Chemicals Pharmaceuticals is 1.91 times less risky than Omeros. The stock trades about -0.07 of its potential returns per unit of risk. The Omeros is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  1,024  in Omeros on October 20, 2024 and sell it today you would lose (91.00) from holding Omeros or give up 8.89% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.24%
Values	Daily Returns

Biofil Chemicals Pharmaceutica  vs.  Omeros

Biofil Chemicals Pha

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biofil Chemicals Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Omeros

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Omeros are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak technical and fundamental indicators, Omeros reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Biofil Chemicals and Omeros

The main advantage of trading using opposite Biofil Chemicals and Omeros positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofil Chemicals position performs unexpectedly, Omeros can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Omeros will offset losses from the drop in Omeros' long position.

The idea behind Biofil Chemicals Pharmaceuticals and Omeros pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.